ライフサイエンスコーパス: cefuroxime

1 Drug Administration-approved amoxicillin and cefuroxime.

2 storage, preparation, and administration of cefuroxime.

3 rophylaxis; all others received cefazolin or cefuroxime.

4 oxacin, 44% against TMP-SMX, and 25% against cefuroxime.

5 hown here to be a target for the beta-lactam cefuroxime.

6 ghly sensitive to the beta-lactam antibiotic cefuroxime.

7 ere sensitive to cephalothin, cefazolin, and cefuroxime.

8 Of the 34 (0.016%) cases of endophthalmitis, cefuroxime 1 mg was injected into 13 eyes and moxifloxac

9 Intracameral cefuroxime (1 mg/0.1 mL) injection, fortified cefuroxime

10 (2 of 74, 2.7%), gram-negative bacilli with cefuroxime (1 of 209, 0.5%), and mixed species with trim

11 treatment started while waiting for surgery (cefuroxime, 1500 mg, and metronidazole, 500 mg, every 8

12 received or did not receive an injection of cefuroxime (5.6% vs 7.3%, respectively [P = .12]).

13 The cephalosporin most commonly involved was cefuroxime (63.6%) (p < 0.0001) in the Spanish cohort an

14 thoprim-sulfamethoxazole (TMP-SMX) (9%), and cefuroxime (7%).

15 ingle-shot, intravenous infusion of 1.5 g of cefuroxime, a commonly used cephalosporin with a short h

16 e recent evidence suggests that intracameral cefuroxime administered at the conclusion of surgery sig

17 bility to hydrolyze cephalosporins including cefuroxime and ceftazidime has been determined by X-ray

18 We find that cefuroxime and ceftriaxone are associated with increased

19 o important issues are the retinal safety of cefuroxime and its use for patients with perioperative c

20 eaction secondary to the use of intracameral cefuroxime and lidocaine during the surgery.

21 gnificantly more severe in rats treated with cefuroxime and other beta-lactams.

22 The beta-lactam ampicillin, in contrast to cefuroxime and penicillin, did not enhance encephalomyel

23 effect relationship between the injection of cefuroxime and POE.

24 d by the inhibitory beta-lactams cefotaxime, cefuroxime, and cefoxitin.

25 valuated the combination of lansoprazole and cefuroxime (another cephalosporin), which lacked evidenc

26 and safety of the prophylactic injection of cefuroxime as measured by the incidence of POE and cysto

27 mg/L, cefetamet and cefixime at 0.0313 mg/L, cefuroxime at 0.0156 mg/L, tedizolid at 0.0625 mg/L, spe

28 HRV may occur following intracameral cefuroxime at recommended doses in complicated cataract

29 tine practice, the intracameral injection of cefuroxime at the conclusion of cataract surgery is asso

30 d endophthalmitis despite receiving a SAP by cefuroxime at the end of cataract surgery.

31 antibiotic prophylaxis via intracameral with cefuroxime (ATB-P IC) in a high-volume cataract surgery

32 in 101, cefazolin in 96, cefaclor in 82, and cefuroxime axetil and ceftriaxone in 22 subjects) were w

33 Cefprozil, cefuroxime axetil and clarithromycin had significant inc

34 ficacy of oral doxycycline, amoxicillin, and cefuroxime axetil for treating Lyme disease has been est

35 nostril twice daily for 3 days and 250 mg of cefuroxime axetil twice daily for 10 days.

36 oup B participants underwent challenges with cefuroxime axetil, ceftriaxone, cefazolin, and ceftibute

37 vaccine, ceftriaxone, lidocaine, omalizumab, cefuroxime, benzylpenicillin, clindamycin, amoxicillin/c

38 lturing with increasing vancomycin (VAN) and cefuroxime (CEF) concentrations, we isolated an evolved

39 tant is sensitive to beta-lactams, including cefuroxime (CEF), and to fosfomycin but that resistant m

40 cillin G, ampicillin, cephalothin, cefaclor, cefuroxime, cefoperazone, and cefotaxime) were isolated,

41 itive responses to 1 or more of ceftriaxone, cefuroxime, cefotaxime, cefepime, cefodizime, and ceftaz

42 am antibiotics containing an oxyimino group (cefuroxime, cefotaxime, ceftriaxone, ceftazidime, or azt

43 cted for increased resistance to cefotaxime, cefuroxime, ceftazadime, and aztreonam, i.e., the "exten

44 l subjects had negative skin test results to cefuroxime, ceftriaxone, and aztreonam and tolerated cha

45 of cross-reactivity between penicillins and cefuroxime, ceftriaxone, and aztreonam in all subjects w

46 erefore these subjects could be treated with cefuroxime, ceftriaxone, and aztreonam.

47 tests with cephalexin, cefaclor, cefadroxil, cefuroxime, ceftriaxone, and aztreonam.

48 , amoxicillin clavulanic acid, azithromycin, cefuroxime, cephalexin, clindamycin, sulfamethoxazole-tr

49 aocular antibiotics, such as moxifloxacin or cefuroxime, delivered intraoperatively have reduced the

50 A subgroup treated prophylactically with cefuroxime demonstrated that SAP alone does not prevent

51 A 30-micrograms cefuroxime disk is proposed: strains with zones > or = 2

52 A zone of inhibition around the cefuroxime disk of >/=32 mm correctly categorized 101 of

53 > or = 26 mm indicating susceptibility, but cefuroxime disks are preferred.

54 The cefuroxime doses administered to the presented patients

55 ible to penicillin, amoxicillin, cefotaxime, cefuroxime, erythromycin, chloramphenicol, vancomycin, q

56 of moxifloxacin-injected eyes and 0.013% of cefuroxime eyes (relative risk 1.62 with 95% CI 0.82-3.2

57 generally related to organism resistance in cefuroxime eyes but to sensitive organisms in moxifloxac

58 dget impact of using Aprokam over unlicensed cefuroxime for intracameral administration.

59 In this study, double-dose SAP with cefuroxime for patients weighing at least 80 kg was not

60 arriers received vancomycin and cefazolin or cefuroxime for perioperative prophylaxis; all others rec

61 recommend a weight-adopted dose increase of cefuroxime for surgical antimicrobial prophylaxis (SAP).

62 ion, quality assurance, or administration of cefuroxime formulations.

63 ylometazoline and antimicrobial therapy with cefuroxime improves clinical success rates and accelerat

64 m cefuroxime-injected eyes were resistant to cefuroxime in all cases (4/4), with Enterococcus compris

65 are but serious complication of intracameral cefuroxime in complicated cataract surgeries and to impr

66 ycin and the commercial unavailability of IC cefuroxime in many countries, moxifloxacin appears to be

67 much higher than in other reported cases of cefuroxime-induced toxicity.

68 Of these, bacteria recovered from cefuroxime-injected eyes were resistant to cefuroxime in

69 In clinical studies, an intracameral cefuroxime injection at the end of surgery was found to

70 ma, was not increased for patients receiving cefuroxime injections (odds ratio, 0.86 [95% CI, 0.71-1.

71 Intracameral cefuroxime is commonly used during cataract surgery to p

72 Intracameral cefuroxime is recommended as prophylaxis against postope

73 xis of POE, although unlicensed intracameral cefuroxime may be administered using pre-filled syringes

74 the risk of POE was reduced with the use of cefuroxime (odds ratio, 0.61 [95% CI, 0.56-0.68]).

75 efuroxime (1 mg/0.1 mL) injection, fortified cefuroxime ophthalmic suspension (50 mg/mL) and moxiflox

76 intake, intravenous antibiotic therapy (ie, cefuroxime or ceftriaxone plus metronidazole or ampicill

77 yelin basic protein T-cell line treated with cefuroxime or penicillin was more encephalitogenic in ad

78 In cases of intracameral cefuroxime overdose, hemorrhagic retinal infarction can

79 ectively [P = .001 for trend]) as the use of cefuroxime prophylactic injections increased (11.1%, 14.

80 , PCR occurred in 278 eyes, and intracameral cefuroxime prophylaxis at the standard dose (1 mg/0.1 mL

81 site of pyruvate carboxylase (PycA) rescued cefuroxime resistance and resulted in a 100-fold increas

82 owever, sigma(M) still plays a major role in cefuroxime resistance even in cells lacking PBP1.

83 racterized suppressor mutations that restore cefuroxime resistance to a sigM null mutant.

84 DeltadacA mutant in rich medium and restored cefuroxime resistance.

85 ongest signal detection with anaphylaxis was cefuroxime (ROR, 40.89 [95% CI, 40.18-41.61]; IC, 5.14 [

86 Timing of cefuroxime SAP administration before incision was divide

87 underwent 9 major surgical procedures with a cefuroxime SAP administration from the Swissnoso SSI sur

88 In this cohort study, administration of cefuroxime SAP closer to the incision time was associate

89 ificantly lower odds of SSI, suggesting that cefuroxime SAP should be administrated within 60 minutes

90 Cefuroxime SAP was administered 61 to 120 minutes prior

91 rwent 1 of 11 major surgical procedures with cefuroxime SAP, documented by the Swissnoso SSI surveill

92 Intracameral injection of cefuroxime sodium (1 mg/0.1 mL) has been reported to red

93 Intracameral injection of cefuroxime sodium at a dose of 9 mg/0.1 mL was associate

94 eyes that received intracameral injection of cefuroxime sodium, 9 mg/0.1 mL, intraoperatively.

95 he 25 920 patients who received intracameral cefuroxime, suggesting that this approach to antibiotic

96 lower for those who received an injection of cefuroxime than for those who did not (0.37% vs 0.51%, r

97 ctic intravenous cephalosporin (cefazolin or cefuroxime) that began within 8 hours after skin closure

98 ted in T cells stimulated in the presence of cefuroxime; these genes were up-regulated in the presenc

99 Among the eyes treated with cefuroxime, three cases of HRV were identified.

100 .53-5.94) for clonazepam + atorvastatin with cefuroxime to 1.42 (95% CI = 1.00-2.02, p = 0.049) for a

101 n orthopedic patients, change in policy from cefuroxime to flucloxacillin (two doses of 1 g) and sing

102 of intracameral antibiotic prophylaxis with cefuroxime to reduce postoperative infectious endophthal

103 ither prepared in hospital by reconstituting cefuroxime via serial dilution (prepared PFS), or commer

104 a 40% to 50% reduction in risk, intracameral cefuroxime was 100% effective in preventing endophthalmi

105 Double-dose cefuroxime was administered to 13 246 patients (35.2%) a

106 disk diffusion testing with ceftizoxime and cefuroxime was evaluated for use in predicting the susce

107 Cefuroxime was inadvertently injected at a dose higher t

108 h as meropenem, piperacillin/tazobactam, and cefuroxime, were not associated with such a risk.

109 The retinal safety of an injection of cefuroxime, which was assessed by multiadjusted odds of

110 l antimicrobial prophylaxis (SAP), including cefuroxime, within 120 minutes prior to incision.